Shares of Castlight Health Inc (NYSE:CSLT) have earned a consensus rating of “Hold” from the six ratings firms that are covering the firm, Marketbeat.com reports. Three research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12-month price target among analysts that have covered the stock in the last year is $5.00.
Several research firms have recently commented on CSLT. TheStreet cut Castlight Health from a “c-” rating to a “d+” rating in a research note on Monday, August 19th. ValuEngine upgraded Castlight Health from a “sell” rating to a “hold” rating in a research note on Thursday, August 1st. Zacks Investment Research upgraded Castlight Health from a “sell” rating to a “hold” rating in a research note on Tuesday, October 1st. Finally, Cantor Fitzgerald cut Castlight Health from an “overweight” rating to a “neutral” rating in a research report on Tuesday, July 30th.
In other Castlight Health news, EVP Maeve O’meara sold 28,171 shares of the company’s stock in a transaction on Monday, August 19th. The stock was sold at an average price of $1.41, for a total value of $39,721.11. Following the sale, the executive vice president now owns 322,775 shares of the company’s stock, valued at $455,112.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Mangini Siobhan Nolan sold 21,617 shares of the company’s stock in a transaction on Monday, August 19th. The shares were sold at an average price of $1.41, for a total value of $30,479.97. Following the completion of the sale, the chief financial officer now directly owns 281,610 shares in the company, valued at approximately $397,070.10. The disclosure for this sale can be found here. Insiders sold 60,858 shares of company stock worth $86,311 in the last three months. 17.37% of the stock is owned by corporate insiders.
A number of institutional investors have recently bought and sold shares of CSLT. Marshall Wace LLP acquired a new stake in shares of Castlight Health during the first quarter valued at $1,124,000. Acadian Asset Management LLC lifted its position in Castlight Health by 119.0% during the second quarter. Acadian Asset Management LLC now owns 557,923 shares of the software maker’s stock worth $1,802,000 after buying an additional 303,138 shares during the period. Concourse Capital Management LLC purchased a new position in Castlight Health during the second quarter worth about $218,000. Edge Wealth Management LLC lifted its position in Castlight Health by 14.0% during the second quarter. Edge Wealth Management LLC now owns 138,625 shares of the software maker’s stock worth $448,000 after buying an additional 17,000 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. lifted its position in Castlight Health by 48.2% during the second quarter. Connor Clark & Lunn Investment Management Ltd. now owns 123,575 shares of the software maker’s stock worth $399,000 after buying an additional 40,175 shares during the period. 56.00% of the stock is currently owned by institutional investors.
NYSE CSLT traded down $0.03 on Friday, reaching $1.47. The stock had a trading volume of 10,079 shares, compared to its average volume of 541,309. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.88 and a current ratio of 1.88. Castlight Health has a 12-month low of $1.21 and a 12-month high of $4.15. The business’s 50-day moving average price is $1.43 and its 200 day moving average price is $2.60. The stock has a market cap of $216.42 million, a P/E ratio of -9.19 and a beta of 1.54.
Castlight Health (NYSE:CSLT) last released its quarterly earnings results on Tuesday, July 30th. The software maker reported ($0.02) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.01) by ($0.01). Castlight Health had a negative return on equity of 9.28% and a negative net margin of 19.68%. The company had revenue of $35.90 million for the quarter, compared to analysts’ expectations of $36.95 million. During the same quarter last year, the company earned ($0.10) EPS. Castlight Health’s revenue for the quarter was down 5.0% compared to the same quarter last year. On average, sell-side analysts predict that Castlight Health will post -0.2 earnings per share for the current year.
Castlight Health Company Profile
Castlight Health, Inc provides a software-as-a-service platform used for health benefits navigation for employees in the United States. Its platform matches employees to the resources their employers make available to them; managing a condition; and assists them to manage their benefits. The company also offers implementation, user and customer support, and marketplace services.
Recommended Story: How Investors Can Profit from Options Trading
Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.